Astrana Health posts record Q3 revenue and adjusted EBITDA, confirms full‑year guidance

Astrana Health reported third‑quarter 2026 revenue of $1.023.6 million, up 7% year‑over‑year, and adjusted EBITDA of $77.2 million, up 13% YoY. Net income rose to $20.3 million, a 1,782% increase, and free cash flow for the nine‑month period reached $105.4 million. The company also completed the purchase of an independent physician association in Georgia on October 1, 2026, and reaffirmed its full‑year revenue and adjusted EBITDA outlook.

The company says the record results and continued debt repayment, which lowered net leverage to about 2.2 times, support its ability to meet the full‑year guidance of $3.9‑$4.0 billion revenue and $261‑$274 million adjusted EBITDA (the company’s own guidance).

  • 1Total revenue for Q3 2026 was $1,023.6 million, a 7% increase from the prior year quarter.
  • 2Adjusted EBITDA for Q3 2026 was $77.2 million, up 13% YoY.
  • 3Net income for Q3 2026 was $20.3 million, a 1,782% rise from the prior year quarter.
  • 4Free cash flow for the nine months ended September 30, 2026 was $105.4 million.
  • 5Astrana completed the purchase of an independent physician association in Georgia on October 1, 2026.
  • 6Full‑year 2026 revenue guidance is $3,900 million to $4,000 million.

Sources